nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronedarone—ABCB1—Mitomycin—urinary bladder cancer	0.0913	0.286	CbGbCtD
Dronedarone—ADRA1B—vas deferens—urinary bladder cancer	0.0435	0.212	CbGeAlD
Dronedarone—ALB—Fluorouracil—urinary bladder cancer	0.043	0.134	CbGbCtD
Dronedarone—CYP3A4—Thiotepa—urinary bladder cancer	0.0414	0.13	CbGbCtD
Dronedarone—ABCB1—Gemcitabine—urinary bladder cancer	0.0263	0.0822	CbGbCtD
Dronedarone—ALB—Methotrexate—urinary bladder cancer	0.0237	0.0741	CbGbCtD
Dronedarone—Pulmonary toxicity—Mitomycin—urinary bladder cancer	0.023	0.0855	CcSEcCtD
Dronedarone—ABCB1—Cisplatin—urinary bladder cancer	0.0191	0.0597	CbGbCtD
Dronedarone—ABCB1—Etoposide—urinary bladder cancer	0.0188	0.0587	CbGbCtD
Dronedarone—ABCB1—Doxorubicin—urinary bladder cancer	0.0128	0.04	CbGbCtD
Dronedarone—ABCB1—Methotrexate—urinary bladder cancer	0.0124	0.0388	CbGbCtD
Dronedarone—CYP2D6—Doxorubicin—urinary bladder cancer	0.0121	0.0377	CbGbCtD
Dronedarone—CYP3A4—Etoposide—urinary bladder cancer	0.0112	0.0352	CbGbCtD
Dronedarone—Pulmonary toxicity—Gemcitabine—urinary bladder cancer	0.00974	0.0362	CcSEcCtD
Dronedarone—Ageusia—Valrubicin—urinary bladder cancer	0.00936	0.0348	CcSEcCtD
Dronedarone—Pulmonary toxicity—Cisplatin—urinary bladder cancer	0.00907	0.0337	CcSEcCtD
Dronedarone—CACNB4—prostate gland—urinary bladder cancer	0.00852	0.0416	CbGeAlD
Dronedarone—CYP3A4—Doxorubicin—urinary bladder cancer	0.00766	0.024	CbGbCtD
Dronedarone—KCNK2—prostate gland—urinary bladder cancer	0.00755	0.0369	CbGeAlD
Dronedarone—HCN3—vagina—urinary bladder cancer	0.00682	0.0333	CbGeAlD
Dronedarone—CACNB1—prostate gland—urinary bladder cancer	0.0068	0.0332	CbGeAlD
Dronedarone—CACNB3—prostate gland—urinary bladder cancer	0.00653	0.0318	CbGeAlD
Dronedarone—CACNA1S—seminal vesicle—urinary bladder cancer	0.00617	0.0301	CbGeAlD
Dronedarone—CACNB3—seminal vesicle—urinary bladder cancer	0.00552	0.0269	CbGeAlD
Dronedarone—Pulmonary fibrosis—Gemcitabine—urinary bladder cancer	0.00503	0.0187	CcSEcCtD
Dronedarone—Pulmonary toxicity—Methotrexate—urinary bladder cancer	0.00498	0.0185	CcSEcCtD
Dronedarone—CACNB2—prostate gland—urinary bladder cancer	0.00438	0.0214	CbGeAlD
Dronedarone—CACNB3—urethra—urinary bladder cancer	0.00437	0.0213	CbGeAlD
Dronedarone—Pulmonary fibrosis—Etoposide—urinary bladder cancer	0.00429	0.0159	CcSEcCtD
Dronedarone—Pneumonia—Valrubicin—urinary bladder cancer	0.00427	0.0159	CcSEcCtD
Dronedarone—CACNB4—vagina—urinary bladder cancer	0.00421	0.0205	CbGeAlD
Dronedarone—Cardiac failure congestive—Mitomycin—urinary bladder cancer	0.00418	0.0155	CcSEcCtD
Dronedarone—CACNA1D—prostate gland—urinary bladder cancer	0.00383	0.0187	CbGeAlD
Dronedarone—ADRA1D—prostate gland—urinary bladder cancer	0.0038	0.0185	CbGeAlD
Dronedarone—KCNK2—vagina—urinary bladder cancer	0.00373	0.0182	CbGeAlD
Dronedarone—CYP3A4—urine—urinary bladder cancer	0.00364	0.0178	CbGeAlD
Dronedarone—CYP2D6—urine—urinary bladder cancer	0.00358	0.0175	CbGeAlD
Dronedarone—CACNB3—female reproductive system—urinary bladder cancer	0.00356	0.0174	CbGeAlD
Dronedarone—CACNA1C—prostate gland—urinary bladder cancer	0.00354	0.0173	CbGeAlD
Dronedarone—Hypomagnesaemia—Gemcitabine—urinary bladder cancer	0.00348	0.0129	CcSEcCtD
Dronedarone—CACNB3—vagina—urinary bladder cancer	0.00322	0.0157	CbGeAlD
Dronedarone—Interstitial lung disease—Gemcitabine—urinary bladder cancer	0.00312	0.0116	CcSEcCtD
Dronedarone—Dermatitis atopic—Gemcitabine—urinary bladder cancer	0.00299	0.0111	CcSEcCtD
Dronedarone—ADRA1D—epithelium—urinary bladder cancer	0.00279	0.0136	CbGeAlD
Dronedarone—ADRB1—prostate gland—urinary bladder cancer	0.00276	0.0135	CbGeAlD
Dronedarone—Interstitial lung disease—Etoposide—urinary bladder cancer	0.00267	0.00991	CcSEcCtD
Dronedarone—ADRA1B—renal system—urinary bladder cancer	0.00265	0.0129	CbGeAlD
Dronedarone—Pulmonary fibrosis—Methotrexate—urinary bladder cancer	0.00257	0.00955	CcSEcCtD
Dronedarone—ADRA1D—urethra—urinary bladder cancer	0.00254	0.0124	CbGeAlD
Dronedarone—Ageusia—Cisplatin—urinary bladder cancer	0.00254	0.00945	CcSEcCtD
Dronedarone—CACNA1C—smooth muscle tissue—urinary bladder cancer	0.0025	0.0122	CbGeAlD
Dronedarone—Liver injury—Cisplatin—urinary bladder cancer	0.00245	0.0091	CcSEcCtD
Dronedarone—KCNK2—lymph node—urinary bladder cancer	0.00241	0.0118	CbGeAlD
Dronedarone—Leukocytoclastic vasculitis—Methotrexate—urinary bladder cancer	0.00231	0.00856	CcSEcCtD
Dronedarone—Erythema—Mitomycin—urinary bladder cancer	0.00228	0.00848	CcSEcCtD
Dronedarone—Vasculitis—Gemcitabine—urinary bladder cancer	0.00226	0.00841	CcSEcCtD
Dronedarone—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.00221	0.00822	CcSEcCtD
Dronedarone—ADRA1A—prostate gland—urinary bladder cancer	0.00218	0.0106	CbGeAlD
Dronedarone—CACNB1—lymph node—urinary bladder cancer	0.00217	0.0106	CbGeAlD
Dronedarone—CACNB2—vagina—urinary bladder cancer	0.00216	0.0106	CbGeAlD
Dronedarone—Abdominal pain—Valrubicin—urinary bladder cancer	0.00214	0.00795	CcSEcCtD
Dronedarone—KCNH2—prostate gland—urinary bladder cancer	0.00211	0.0103	CbGeAlD
Dronedarone—CACNB3—lymph node—urinary bladder cancer	0.00208	0.0102	CbGeAlD
Dronedarone—ADRA2C—prostate gland—urinary bladder cancer	0.00208	0.0101	CbGeAlD
Dronedarone—ADRA1D—female reproductive system—urinary bladder cancer	0.00207	0.0101	CbGeAlD
Dronedarone—Cardiac failure—Thiotepa—urinary bladder cancer	0.00195	0.00726	CcSEcCtD
Dronedarone—Asthenia—Valrubicin—urinary bladder cancer	0.00194	0.00721	CcSEcCtD
Dronedarone—CACNA1C—female reproductive system—urinary bladder cancer	0.00193	0.00942	CbGeAlD
Dronedarone—Pruritus—Valrubicin—urinary bladder cancer	0.00191	0.00711	CcSEcCtD
Dronedarone—Diarrhoea—Valrubicin—urinary bladder cancer	0.00185	0.00688	CcSEcCtD
Dronedarone—Blood creatinine increased—Thiotepa—urinary bladder cancer	0.00179	0.00664	CcSEcCtD
Dronedarone—KCNH2—seminal vesicle—urinary bladder cancer	0.00178	0.0087	CbGeAlD
Dronedarone—Cardiac failure congestive—Gemcitabine—urinary bladder cancer	0.00177	0.00657	CcSEcCtD
Dronedarone—ADRA2C—seminal vesicle—urinary bladder cancer	0.00176	0.00858	CbGeAlD
Dronedarone—CACNA1C—vagina—urinary bladder cancer	0.00175	0.00852	CbGeAlD
Dronedarone—Vomiting—Valrubicin—urinary bladder cancer	0.00172	0.00639	CcSEcCtD
Dronedarone—Rash—Valrubicin—urinary bladder cancer	0.00171	0.00634	CcSEcCtD
Dronedarone—Dermatitis—Valrubicin—urinary bladder cancer	0.0017	0.00633	CcSEcCtD
Dronedarone—Hypomagnesaemia—Epirubicin—urinary bladder cancer	0.00167	0.00619	CcSEcCtD
Dronedarone—ADRA2A—prostate gland—urinary bladder cancer	0.00166	0.0081	CbGeAlD
Dronedarone—Cardiac failure congestive—Cisplatin—urinary bladder cancer	0.00165	0.00613	CcSEcCtD
Dronedarone—Cardiac failure—Gemcitabine—urinary bladder cancer	0.00164	0.00611	CcSEcCtD
Dronedarone—Cardiac failure—Fluorouracil—urinary bladder cancer	0.00162	0.006	CcSEcCtD
Dronedarone—Nausea—Valrubicin—urinary bladder cancer	0.00161	0.00597	CcSEcCtD
Dronedarone—Fatigue—Mitomycin—urinary bladder cancer	0.00161	0.00597	CcSEcCtD
Dronedarone—ADRA1A—epithelium—urinary bladder cancer	0.0016	0.00782	CbGeAlD
Dronedarone—Interstitial lung disease—Methotrexate—urinary bladder cancer	0.0016	0.00593	CcSEcCtD
Dronedarone—Hypomagnesaemia—Doxorubicin—urinary bladder cancer	0.00154	0.00572	CcSEcCtD
Dronedarone—Cardiac failure congestive—Etoposide—urinary bladder cancer	0.00151	0.00561	CcSEcCtD
Dronedarone—ADRB1—female reproductive system—urinary bladder cancer	0.00151	0.00735	CbGeAlD
Dronedarone—Blood creatinine increased—Gemcitabine—urinary bladder cancer	0.0015	0.00558	CcSEcCtD
Dronedarone—ADRA1A—renal system—urinary bladder cancer	0.00149	0.00726	CbGeAlD
Dronedarone—Pneumonia—Thiotepa—urinary bladder cancer	0.00148	0.00549	CcSEcCtD
Dronedarone—Hypokalaemia—Gemcitabine—urinary bladder cancer	0.00146	0.00542	CcSEcCtD
Dronedarone—KCNH2—renal system—urinary bladder cancer	0.00144	0.00701	CbGeAlD
Dronedarone—Dermatitis atopic—Epirubicin—urinary bladder cancer	0.00143	0.00531	CcSEcCtD
Dronedarone—ADRA2C—renal system—urinary bladder cancer	0.00142	0.00692	CbGeAlD
Dronedarone—KCNH2—urethra—urinary bladder cancer	0.00141	0.00688	CbGeAlD
Dronedarone—Cardiac failure—Etoposide—urinary bladder cancer	0.0014	0.00522	CcSEcCtD
Dronedarone—ADRA2A—seminal vesicle—urinary bladder cancer	0.0014	0.00685	CbGeAlD
Dronedarone—Blood creatinine increased—Cisplatin—urinary bladder cancer	0.0014	0.0052	CcSEcCtD
Dronedarone—CACNB2—lymph node—urinary bladder cancer	0.0014	0.00683	CbGeAlD
Dronedarone—ADRA2C—urethra—urinary bladder cancer	0.00139	0.00679	CbGeAlD
Dronedarone—Hepatobiliary disease—Thiotepa—urinary bladder cancer	0.00139	0.00516	CcSEcCtD
Dronedarone—Rash erythematous—Epirubicin—urinary bladder cancer	0.00138	0.00513	CcSEcCtD
Dronedarone—Hypokalaemia—Cisplatin—urinary bladder cancer	0.00136	0.00506	CcSEcCtD
Dronedarone—Asthenia—Mitomycin—urinary bladder cancer	0.00134	0.00497	CcSEcCtD
Dronedarone—Dermatitis atopic—Doxorubicin—urinary bladder cancer	0.00132	0.00491	CcSEcCtD
Dronedarone—Ageusia—Epirubicin—urinary bladder cancer	0.00131	0.00485	CcSEcCtD
Dronedarone—Rash erythematous—Doxorubicin—urinary bladder cancer	0.00128	0.00475	CcSEcCtD
Dronedarone—Diarrhoea—Mitomycin—urinary bladder cancer	0.00128	0.00474	CcSEcCtD
Dronedarone—Liver injury—Epirubicin—urinary bladder cancer	0.00126	0.00467	CcSEcCtD
Dronedarone—Photosensitivity reaction—Fluorouracil—urinary bladder cancer	0.00124	0.00462	CcSEcCtD
Dronedarone—Pneumonia—Gemcitabine—urinary bladder cancer	0.00124	0.00462	CcSEcCtD
Dronedarone—Cardiac disorder—Thiotepa—urinary bladder cancer	0.00122	0.00455	CcSEcCtD
Dronedarone—CACNA1D—lymph node—urinary bladder cancer	0.00122	0.00597	CbGeAlD
Dronedarone—Pneumonia—Fluorouracil—urinary bladder cancer	0.00122	0.00454	CcSEcCtD
Dronedarone—Ageusia—Doxorubicin—urinary bladder cancer	0.00121	0.00449	CcSEcCtD
Dronedarone—Angiopathy—Thiotepa—urinary bladder cancer	0.0012	0.00445	CcSEcCtD
Dronedarone—Immune system disorder—Thiotepa—urinary bladder cancer	0.00119	0.00443	CcSEcCtD
Dronedarone—Mediastinal disorder—Thiotepa—urinary bladder cancer	0.00119	0.00442	CcSEcCtD
Dronedarone—Vomiting—Mitomycin—urinary bladder cancer	0.00119	0.0044	CcSEcCtD
Dronedarone—Rash—Mitomycin—urinary bladder cancer	0.00118	0.00437	CcSEcCtD
Dronedarone—Dermatitis—Mitomycin—urinary bladder cancer	0.00117	0.00436	CcSEcCtD
Dronedarone—Hepatobiliary disease—Gemcitabine—urinary bladder cancer	0.00117	0.00434	CcSEcCtD
Dronedarone—Liver injury—Doxorubicin—urinary bladder cancer	0.00116	0.00432	CcSEcCtD
Dronedarone—Vasculitis—Methotrexate—urinary bladder cancer	0.00116	0.0043	CcSEcCtD
Dronedarone—KCNH2—female reproductive system—urinary bladder cancer	0.00115	0.00561	CbGeAlD
Dronedarone—Erythema—Thiotepa—urinary bladder cancer	0.00115	0.00427	CcSEcCtD
Dronedarone—CACNA1C—lymph node—urinary bladder cancer	0.00113	0.00551	CbGeAlD
Dronedarone—ADRA2A—urethra—urinary bladder cancer	0.00111	0.00542	CbGeAlD
Dronedarone—Nausea—Mitomycin—urinary bladder cancer	0.00111	0.00411	CcSEcCtD
Dronedarone—Hepatobiliary disease—Cisplatin—urinary bladder cancer	0.00109	0.00405	CcSEcCtD
Dronedarone—Pneumonia—Etoposide—urinary bladder cancer	0.00106	0.00394	CcSEcCtD
Dronedarone—Bradycardia—Cisplatin—urinary bladder cancer	0.00105	0.00391	CcSEcCtD
Dronedarone—KCNH2—vagina—urinary bladder cancer	0.00104	0.00508	CbGeAlD
Dronedarone—Cardiac disorder—Gemcitabine—urinary bladder cancer	0.00103	0.00383	CcSEcCtD
Dronedarone—ADRA2C—vagina—urinary bladder cancer	0.00103	0.00501	CbGeAlD
Dronedarone—Angiopathy—Gemcitabine—urinary bladder cancer	0.00101	0.00374	CcSEcCtD
Dronedarone—Immune system disorder—Gemcitabine—urinary bladder cancer	0.001	0.00372	CcSEcCtD
Dronedarone—Mediastinal disorder—Gemcitabine—urinary bladder cancer	0.001	0.00372	CcSEcCtD
Dronedarone—Hepatobiliary disease—Etoposide—urinary bladder cancer	0.000999	0.00371	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.000971	0.00361	CcSEcCtD
Dronedarone—Erythema—Gemcitabine—urinary bladder cancer	0.000966	0.00359	CcSEcCtD
Dronedarone—Cardiac disorder—Cisplatin—urinary bladder cancer	0.00096	0.00357	CcSEcCtD
Dronedarone—Erythema—Fluorouracil—urinary bladder cancer	0.00095	0.00353	CcSEcCtD
Dronedarone—Immune system disorder—Cisplatin—urinary bladder cancer	0.000934	0.00347	CcSEcCtD
Dronedarone—Mediastinal disorder—Cisplatin—urinary bladder cancer	0.000932	0.00346	CcSEcCtD
Dronedarone—ABCB1—prostate gland—urinary bladder cancer	0.000925	0.00451	CbGeAlD
Dronedarone—Nervous system disorder—Thiotepa—urinary bladder cancer	0.000919	0.00342	CcSEcCtD
Dronedarone—Skin disorder—Thiotepa—urinary bladder cancer	0.000911	0.00338	CcSEcCtD
Dronedarone—ADRA2A—female reproductive system—urinary bladder cancer	0.000906	0.00442	CbGeAlD
Dronedarone—Erythema—Cisplatin—urinary bladder cancer	0.000901	0.00335	CcSEcCtD
Dronedarone—CYP3A4—renal system—urinary bladder cancer	0.00089	0.00434	CbGeAlD
Dronedarone—Cardiac disorder—Etoposide—urinary bladder cancer	0.00088	0.00327	CcSEcCtD
Dronedarone—ALB—lymph node—urinary bladder cancer	0.000876	0.00427	CbGeAlD
Dronedarone—CYP2D6—renal system—urinary bladder cancer	0.000876	0.00427	CbGeAlD
Dronedarone—Angiopathy—Etoposide—urinary bladder cancer	0.00086	0.00319	CcSEcCtD
Dronedarone—Immune system disorder—Etoposide—urinary bladder cancer	0.000856	0.00318	CcSEcCtD
Dronedarone—Eczema—Epirubicin—urinary bladder cancer	0.000855	0.00317	CcSEcCtD
Dronedarone—Mediastinal disorder—Etoposide—urinary bladder cancer	0.000854	0.00317	CcSEcCtD
Dronedarone—Cardiac failure congestive—Epirubicin—urinary bladder cancer	0.000847	0.00315	CcSEcCtD
Dronedarone—Dyspepsia—Thiotepa—urinary bladder cancer	0.000825	0.00307	CcSEcCtD
Dronedarone—ADRA2A—vagina—urinary bladder cancer	0.000819	0.004	CbGeAlD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.000817	0.00303	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000809	0.00301	CcSEcCtD
Dronedarone—Fatigue—Thiotepa—urinary bladder cancer	0.000808	0.003	CcSEcCtD
Dronedarone—Dysgeusia—Etoposide—urinary bladder cancer	0.000808	0.003	CcSEcCtD
Dronedarone—Eczema—Doxorubicin—urinary bladder cancer	0.000791	0.00294	CcSEcCtD
Dronedarone—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000789	0.00293	CcSEcCtD
Dronedarone—Cardiac failure—Epirubicin—urinary bladder cancer	0.000787	0.00292	CcSEcCtD
Dronedarone—Cardiac failure congestive—Doxorubicin—urinary bladder cancer	0.000784	0.00291	CcSEcCtD
Dronedarone—ABCB1—seminal vesicle—urinary bladder cancer	0.000782	0.00382	CbGeAlD
Dronedarone—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000775	0.00288	CcSEcCtD
Dronedarone—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000773	0.00287	CcSEcCtD
Dronedarone—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000767	0.00285	CcSEcCtD
Dronedarone—Skin disorder—Gemcitabine—urinary bladder cancer	0.000766	0.00285	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000761	0.00283	CcSEcCtD
Dronedarone—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00076	0.00282	CcSEcCtD
Dronedarone—Abdominal pain—Thiotepa—urinary bladder cancer	0.000741	0.00275	CcSEcCtD
Dronedarone—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000735	0.00273	CcSEcCtD
Dronedarone—Cardiac failure—Doxorubicin—urinary bladder cancer	0.000728	0.0027	CcSEcCtD
Dronedarone—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000721	0.00268	CcSEcCtD
Dronedarone—Blood creatinine increased—Epirubicin—urinary bladder cancer	0.000719	0.00267	CcSEcCtD
Dronedarone—Skin disorder—Cisplatin—urinary bladder cancer	0.000714	0.00265	CcSEcCtD
Dronedarone—CYP3A4—female reproductive system—urinary bladder cancer	0.000713	0.00348	CbGeAlD
Dronedarone—CYP2D6—female reproductive system—urinary bladder cancer	0.000702	0.00342	CbGeAlD
Dronedarone—Hypokalaemia—Epirubicin—urinary bladder cancer	0.000699	0.0026	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000698	0.00259	CcSEcCtD
Dronedarone—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000683	0.00254	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000681	0.00253	CcSEcCtD
Dronedarone—Fatigue—Gemcitabine—urinary bladder cancer	0.00068	0.00253	CcSEcCtD
Dronedarone—ABCB1—epithelium—urinary bladder cancer	0.000679	0.00331	CbGeAlD
Dronedarone—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000673	0.0025	CcSEcCtD
Dronedarone—KCNH2—lymph node—urinary bladder cancer	0.000673	0.00328	CbGeAlD
Dronedarone—Asthenia—Thiotepa—urinary bladder cancer	0.000673	0.0025	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000669	0.00249	CcSEcCtD
Dronedarone—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.000666	0.00247	CcSEcCtD
Dronedarone—ADRA2C—lymph node—urinary bladder cancer	0.000664	0.00324	CbGeAlD
Dronedarone—Pruritus—Thiotepa—urinary bladder cancer	0.000663	0.00246	CcSEcCtD
Dronedarone—Skin disorder—Etoposide—urinary bladder cancer	0.000654	0.00243	CcSEcCtD
Dronedarone—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000647	0.00241	CcSEcCtD
Dronedarone—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.000647	0.0024	CcSEcCtD
Dronedarone—Diarrhoea—Thiotepa—urinary bladder cancer	0.000641	0.00238	CcSEcCtD
Dronedarone—Pneumonia—Methotrexate—urinary bladder cancer	0.000636	0.00236	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000635	0.00236	CcSEcCtD
Dronedarone—ABCB1—renal system—urinary bladder cancer	0.00063	0.00307	CbGeAlD
Dronedarone—ABCB1—urethra—urinary bladder cancer	0.000619	0.00302	CbGeAlD
Dronedarone—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000606	0.00225	CcSEcCtD
Dronedarone—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000598	0.00222	CcSEcCtD
Dronedarone—Vomiting—Thiotepa—urinary bladder cancer	0.000596	0.00221	CcSEcCtD
Dronedarone—Pneumonia—Epirubicin—urinary bladder cancer	0.000595	0.00221	CcSEcCtD
Dronedarone—Rash—Thiotepa—urinary bladder cancer	0.000591	0.0022	CcSEcCtD
Dronedarone—Dermatitis—Thiotepa—urinary bladder cancer	0.000591	0.00219	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000581	0.00216	CcSEcCtD
Dronedarone—Fatigue—Etoposide—urinary bladder cancer	0.000581	0.00216	CcSEcCtD
Dronedarone—Asthenia—Gemcitabine—urinary bladder cancer	0.000566	0.0021	CcSEcCtD
Dronedarone—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000561	0.00208	CcSEcCtD
Dronedarone—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.00056	0.00208	CcSEcCtD
Dronedarone—Pruritus—Gemcitabine—urinary bladder cancer	0.000558	0.00207	CcSEcCtD
Dronedarone—Nausea—Thiotepa—urinary bladder cancer	0.000557	0.00207	CcSEcCtD
Dronedarone—Pneumonia—Doxorubicin—urinary bladder cancer	0.000551	0.00205	CcSEcCtD
Dronedarone—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000551	0.00205	CcSEcCtD
Dronedarone—Pruritus—Fluorouracil—urinary bladder cancer	0.000549	0.00204	CcSEcCtD
Dronedarone—Bradycardia—Epirubicin—urinary bladder cancer	0.000541	0.00201	CcSEcCtD
Dronedarone—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00054	0.002	CcSEcCtD
Dronedarone—Abdominal pain—Etoposide—urinary bladder cancer	0.000532	0.00198	CcSEcCtD
Dronedarone—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000531	0.00197	CcSEcCtD
Dronedarone—ADRA2A—lymph node—urinary bladder cancer	0.00053	0.00259	CbGeAlD
Dronedarone—Asthenia—Cisplatin—urinary bladder cancer	0.000527	0.00196	CcSEcCtD
Dronedarone—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000527	0.00196	CcSEcCtD
Dronedarone—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000518	0.00192	CcSEcCtD
Dronedarone—Angiopathy—Methotrexate—urinary bladder cancer	0.000515	0.00191	CcSEcCtD
Dronedarone—Immune system disorder—Methotrexate—urinary bladder cancer	0.000513	0.0019	CcSEcCtD
Dronedarone—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000512	0.0019	CcSEcCtD
Dronedarone—ABCB1—female reproductive system—urinary bladder cancer	0.000505	0.00246	CbGeAlD
Dronedarone—Diarrhoea—Cisplatin—urinary bladder cancer	0.000503	0.00187	CcSEcCtD
Dronedarone—Vomiting—Gemcitabine—urinary bladder cancer	0.000501	0.00186	CcSEcCtD
Dronedarone—Bradycardia—Doxorubicin—urinary bladder cancer	0.0005	0.00186	CcSEcCtD
Dronedarone—Rash—Gemcitabine—urinary bladder cancer	0.000497	0.00185	CcSEcCtD
Dronedarone—Dermatitis—Gemcitabine—urinary bladder cancer	0.000497	0.00185	CcSEcCtD
Dronedarone—Erythema—Methotrexate—urinary bladder cancer	0.000494	0.00184	CcSEcCtD
Dronedarone—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000493	0.00183	CcSEcCtD
Dronedarone—Vomiting—Fluorouracil—urinary bladder cancer	0.000493	0.00183	CcSEcCtD
Dronedarone—Rash—Fluorouracil—urinary bladder cancer	0.000489	0.00182	CcSEcCtD
Dronedarone—Dermatitis—Fluorouracil—urinary bladder cancer	0.000488	0.00181	CcSEcCtD
Dronedarone—Dysgeusia—Methotrexate—urinary bladder cancer	0.000484	0.0018	CcSEcCtD
Dronedarone—Asthenia—Etoposide—urinary bladder cancer	0.000483	0.00179	CcSEcCtD
Dronedarone—Angiopathy—Epirubicin—urinary bladder cancer	0.000482	0.00179	CcSEcCtD
Dronedarone—Immune system disorder—Epirubicin—urinary bladder cancer	0.00048	0.00178	CcSEcCtD
Dronedarone—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000479	0.00178	CcSEcCtD
Dronedarone—Pruritus—Etoposide—urinary bladder cancer	0.000476	0.00177	CcSEcCtD
Dronedarone—Nausea—Gemcitabine—urinary bladder cancer	0.000468	0.00174	CcSEcCtD
Dronedarone—Vomiting—Cisplatin—urinary bladder cancer	0.000467	0.00174	CcSEcCtD
Dronedarone—Rash—Cisplatin—urinary bladder cancer	0.000463	0.00172	CcSEcCtD
Dronedarone—Dermatitis—Cisplatin—urinary bladder cancer	0.000463	0.00172	CcSEcCtD
Dronedarone—Erythema—Epirubicin—urinary bladder cancer	0.000462	0.00172	CcSEcCtD
Dronedarone—Diarrhoea—Etoposide—urinary bladder cancer	0.000461	0.00171	CcSEcCtD
Dronedarone—Nausea—Fluorouracil—urinary bladder cancer	0.000461	0.00171	CcSEcCtD
Dronedarone—ABCB1—vagina—urinary bladder cancer	0.000456	0.00223	CbGeAlD
Dronedarone—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000456	0.00169	CcSEcCtD
Dronedarone—Dysgeusia—Epirubicin—urinary bladder cancer	0.000453	0.00168	CcSEcCtD
Dronedarone—Angiopathy—Doxorubicin—urinary bladder cancer	0.000446	0.00166	CcSEcCtD
Dronedarone—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000444	0.00165	CcSEcCtD
Dronedarone—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000443	0.00165	CcSEcCtD
Dronedarone—Nausea—Cisplatin—urinary bladder cancer	0.000437	0.00162	CcSEcCtD
Dronedarone—Vomiting—Etoposide—urinary bladder cancer	0.000428	0.00159	CcSEcCtD
Dronedarone—Erythema—Doxorubicin—urinary bladder cancer	0.000428	0.00159	CcSEcCtD
Dronedarone—Rash—Etoposide—urinary bladder cancer	0.000425	0.00158	CcSEcCtD
Dronedarone—Dermatitis—Etoposide—urinary bladder cancer	0.000424	0.00158	CcSEcCtD
Dronedarone—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000419	0.00156	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000418	0.00155	CcSEcCtD
Dronedarone—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000403	0.0015	CcSEcCtD
Dronedarone—Nausea—Etoposide—urinary bladder cancer	0.0004	0.00149	CcSEcCtD
Dronedarone—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000396	0.00147	CcSEcCtD
Dronedarone—Skin disorder—Methotrexate—urinary bladder cancer	0.000392	0.00146	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000391	0.00145	CcSEcCtD
Dronedarone—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000377	0.0014	CcSEcCtD
Dronedarone—Nervous system disorder—Epirubicin—urinary bladder cancer	0.00037	0.00138	CcSEcCtD
Dronedarone—Skin disorder—Epirubicin—urinary bladder cancer	0.000367	0.00136	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000362	0.00134	CcSEcCtD
Dronedarone—Dyspepsia—Methotrexate—urinary bladder cancer	0.000355	0.00132	CcSEcCtD
Dronedarone—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000349	0.0013	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000348	0.00129	CcSEcCtD
Dronedarone—Fatigue—Methotrexate—urinary bladder cancer	0.000348	0.00129	CcSEcCtD
Dronedarone—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000343	0.00127	CcSEcCtD
Dronedarone—Skin disorder—Doxorubicin—urinary bladder cancer	0.000339	0.00126	CcSEcCtD
Dronedarone—Dyspepsia—Epirubicin—urinary bladder cancer	0.000332	0.00123	CcSEcCtD
Dronedarone—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00033	0.00123	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000326	0.00121	CcSEcCtD
Dronedarone—Fatigue—Epirubicin—urinary bladder cancer	0.000325	0.00121	CcSEcCtD
Dronedarone—Abdominal pain—Methotrexate—urinary bladder cancer	0.000319	0.00118	CcSEcCtD
Dronedarone—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000309	0.00115	CcSEcCtD
Dronedarone—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000307	0.00114	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000302	0.00112	CcSEcCtD
Dronedarone—Fatigue—Doxorubicin—urinary bladder cancer	0.000301	0.00112	CcSEcCtD
Dronedarone—Abdominal pain—Epirubicin—urinary bladder cancer	0.000298	0.00111	CcSEcCtD
Dronedarone—ABCB1—lymph node—urinary bladder cancer	0.000295	0.00144	CbGeAlD
Dronedarone—Asthenia—Methotrexate—urinary bladder cancer	0.000289	0.00108	CcSEcCtD
Dronedarone—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000286	0.00106	CcSEcCtD
Dronedarone—Pruritus—Methotrexate—urinary bladder cancer	0.000285	0.00106	CcSEcCtD
Dronedarone—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000276	0.00103	CcSEcCtD
Dronedarone—Diarrhoea—Methotrexate—urinary bladder cancer	0.000276	0.00103	CcSEcCtD
Dronedarone—Asthenia—Epirubicin—urinary bladder cancer	0.000271	0.00101	CcSEcCtD
Dronedarone—Pruritus—Epirubicin—urinary bladder cancer	0.000267	0.000992	CcSEcCtD
Dronedarone—Diarrhoea—Epirubicin—urinary bladder cancer	0.000258	0.000959	CcSEcCtD
Dronedarone—Vomiting—Methotrexate—urinary bladder cancer	0.000256	0.000953	CcSEcCtD
Dronedarone—Rash—Methotrexate—urinary bladder cancer	0.000254	0.000945	CcSEcCtD
Dronedarone—Dermatitis—Methotrexate—urinary bladder cancer	0.000254	0.000944	CcSEcCtD
Dronedarone—Asthenia—Doxorubicin—urinary bladder cancer	0.000251	0.000931	CcSEcCtD
Dronedarone—Pruritus—Doxorubicin—urinary bladder cancer	0.000247	0.000918	CcSEcCtD
Dronedarone—Vomiting—Epirubicin—urinary bladder cancer	0.00024	0.000892	CcSEcCtD
Dronedarone—Nausea—Methotrexate—urinary bladder cancer	0.00024	0.00089	CcSEcCtD
Dronedarone—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000239	0.000888	CcSEcCtD
Dronedarone—Rash—Epirubicin—urinary bladder cancer	0.000238	0.000884	CcSEcCtD
Dronedarone—Dermatitis—Epirubicin—urinary bladder cancer	0.000238	0.000883	CcSEcCtD
Dronedarone—Nausea—Epirubicin—urinary bladder cancer	0.000224	0.000833	CcSEcCtD
Dronedarone—Vomiting—Doxorubicin—urinary bladder cancer	0.000222	0.000825	CcSEcCtD
Dronedarone—Rash—Doxorubicin—urinary bladder cancer	0.00022	0.000818	CcSEcCtD
Dronedarone—Dermatitis—Doxorubicin—urinary bladder cancer	0.00022	0.000817	CcSEcCtD
Dronedarone—Nausea—Doxorubicin—urinary bladder cancer	0.000207	0.000771	CcSEcCtD
Dronedarone—ADRA1A—Signaling by GPCR—RHOA—urinary bladder cancer	1.89e-05	9.19e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—ERCC2—urinary bladder cancer	1.88e-05	9.1e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—CXCL8—urinary bladder cancer	1.87e-05	9.08e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—KRAS—urinary bladder cancer	1.86e-05	9.01e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—S100B—urinary bladder cancer	1.86e-05	9e-05	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.83e-05	8.88e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—EP300—urinary bladder cancer	1.82e-05	8.84e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—IL2—urinary bladder cancer	1.82e-05	8.82e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TERT—urinary bladder cancer	1.81e-05	8.78e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.8e-05	8.73e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—NCOR1—urinary bladder cancer	1.8e-05	8.71e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—FGFR3—urinary bladder cancer	1.8e-05	8.71e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—IL2—urinary bladder cancer	1.79e-05	8.68e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TERT—urinary bladder cancer	1.78e-05	8.64e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—FGFR3—urinary bladder cancer	1.78e-05	8.63e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—SRC—urinary bladder cancer	1.77e-05	8.59e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—MTHFR—urinary bladder cancer	1.76e-05	8.56e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PPARG—urinary bladder cancer	1.76e-05	8.54e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—RHOA—urinary bladder cancer	1.76e-05	8.53e-05	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—IL2—urinary bladder cancer	1.75e-05	8.49e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—ESR1—urinary bladder cancer	1.74e-05	8.46e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.74e-05	8.43e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—ESR1—urinary bladder cancer	1.73e-05	8.38e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.72e-05	8.35e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—GSTP1—urinary bladder cancer	1.71e-05	8.31e-05	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.7e-05	8.25e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.7e-05	8.23e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—CREBBP—urinary bladder cancer	1.69e-05	8.21e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CREBBP—urinary bladder cancer	1.68e-05	8.14e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—NCOR1—urinary bladder cancer	1.67e-05	8.09e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—CXCL8—urinary bladder cancer	1.66e-05	8.06e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—FGFR3—urinary bladder cancer	1.66e-05	8.06e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.66e-05	8.04e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IGF1—urinary bladder cancer	1.66e-05	8.03e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—TP53—urinary bladder cancer	1.65e-05	8.01e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—EGFR—urinary bladder cancer	1.65e-05	7.99e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—FGFR3—urinary bladder cancer	1.64e-05	7.93e-05	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—IL2—urinary bladder cancer	1.63e-05	7.88e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—ESR1—urinary bladder cancer	1.61e-05	7.83e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—TYMS—urinary bladder cancer	1.59e-05	7.73e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—IL2—urinary bladder cancer	1.59e-05	7.71e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—ESR1—urinary bladder cancer	1.59e-05	7.7e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TERT—urinary bladder cancer	1.58e-05	7.68e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—HRAS—urinary bladder cancer	1.58e-05	7.66e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—NCOR1—urinary bladder cancer	1.58e-05	7.64e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—GSTM1—urinary bladder cancer	1.58e-05	7.64e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—KRAS—urinary bladder cancer	1.56e-05	7.55e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—CXCL8—urinary bladder cancer	1.55e-05	7.49e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CREBBP—urinary bladder cancer	1.53e-05	7.41e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—RHOA—urinary bladder cancer	1.52e-05	7.36e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CREBBP—urinary bladder cancer	1.51e-05	7.35e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IGF1—urinary bladder cancer	1.51e-05	7.32e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—GPX1—urinary bladder cancer	1.51e-05	7.32e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.5e-05	7.28e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—EGFR—urinary bladder cancer	1.5e-05	7.28e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IGF1—urinary bladder cancer	1.5e-05	7.25e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—EGFR—urinary bladder cancer	1.49e-05	7.22e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.49e-05	7.21e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—ERCC2—urinary bladder cancer	1.48e-05	7.18e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—IL2—urinary bladder cancer	1.48e-05	7.16e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TERT—urinary bladder cancer	1.47e-05	7.13e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—KRAS—urinary bladder cancer	1.47e-05	7.11e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—FGFR3—urinary bladder cancer	1.45e-05	7.05e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PPARG—urinary bladder cancer	1.43e-05	6.94e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—KRAS—urinary bladder cancer	1.42e-05	6.88e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.42e-05	6.86e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CREBBP—urinary bladder cancer	1.41e-05	6.86e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—ESR1—urinary bladder cancer	1.41e-05	6.84e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—KRAS—urinary bladder cancer	1.41e-05	6.82e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—ERBB2—urinary bladder cancer	1.41e-05	6.81e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IGF1—urinary bladder cancer	1.4e-05	6.78e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.4e-05	6.77e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CREBBP—urinary bladder cancer	1.39e-05	6.75e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—MTHFR—urinary bladder cancer	1.39e-05	6.75e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—EGFR—urinary bladder cancer	1.39e-05	6.74e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PTGS2—urinary bladder cancer	1.39e-05	6.72e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—RHOA—urinary bladder cancer	1.38e-05	6.71e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.38e-05	6.69e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.38e-05	6.69e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.38e-05	6.68e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.38e-05	6.68e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IGF1—urinary bladder cancer	1.38e-05	6.67e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—CREBBP—urinary bladder cancer	1.37e-05	6.66e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—RHOA—urinary bladder cancer	1.37e-05	6.64e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—EGFR—urinary bladder cancer	1.37e-05	6.64e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—FGFR3—urinary bladder cancer	1.35e-05	6.55e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.34e-05	6.47e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CXCL8—urinary bladder cancer	1.33e-05	6.46e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—HRAS—urinary bladder cancer	1.32e-05	6.42e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.32e-05	6.41e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.32e-05	6.38e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—KRAS—urinary bladder cancer	1.31e-05	6.37e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—ESR1—urinary bladder cancer	1.31e-05	6.36e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—TP53—urinary bladder cancer	1.3e-05	6.32e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.3e-05	6.31e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.3e-05	6.31e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.3e-05	6.29e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—KRAS—urinary bladder cancer	1.29e-05	6.27e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—ERBB2—urinary bladder cancer	1.28e-05	6.21e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—RHOA—urinary bladder cancer	1.28e-05	6.21e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IL2—urinary bladder cancer	1.27e-05	6.17e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—ERBB2—urinary bladder cancer	1.27e-05	6.15e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—RHOA—urinary bladder cancer	1.26e-05	6.11e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—HRAS—urinary bladder cancer	1.25e-05	6.05e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.25e-05	6.04e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CCND1—urinary bladder cancer	1.24e-05	6.02e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CREBBP—urinary bladder cancer	1.24e-05	6e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.22e-05	5.93e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IGF1—urinary bladder cancer	1.22e-05	5.92e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.22e-05	5.92e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—EGFR—urinary bladder cancer	1.22e-05	5.89e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CXCL8—urinary bladder cancer	1.21e-05	5.89e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PTEN—urinary bladder cancer	1.21e-05	5.86e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—HRAS—urinary bladder cancer	1.21e-05	5.85e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MMP9—urinary bladder cancer	1.21e-05	5.84e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CXCL8—urinary bladder cancer	1.2e-05	5.83e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CDKN1A—urinary bladder cancer	1.2e-05	5.82e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—PTEN—urinary bladder cancer	1.2e-05	5.81e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—HRAS—urinary bladder cancer	1.2e-05	5.8e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—ERBB2—urinary bladder cancer	1.18e-05	5.75e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—ERBB2—urinary bladder cancer	1.17e-05	5.65e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IL2—urinary bladder cancer	1.16e-05	5.63e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—EP300—urinary bladder cancer	1.15e-05	5.59e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.15e-05	5.58e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IL2—urinary bladder cancer	1.15e-05	5.57e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CREBBP—urinary bladder cancer	1.15e-05	5.57e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—KRAS—urinary bladder cancer	1.15e-05	5.57e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—EP300—urinary bladder cancer	1.14e-05	5.54e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IGF1—urinary bladder cancer	1.13e-05	5.5e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CCND1—urinary bladder cancer	1.13e-05	5.48e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—EGFR—urinary bladder cancer	1.13e-05	5.48e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PPARG—urinary bladder cancer	1.13e-05	5.48e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PTGS2—urinary bladder cancer	1.13e-05	5.46e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CXCL8—urinary bladder cancer	1.12e-05	5.45e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CCND1—urinary bladder cancer	1.12e-05	5.43e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—RHOA—urinary bladder cancer	1.12e-05	5.43e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—HRAS—urinary bladder cancer	1.12e-05	5.41e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—SRC—urinary bladder cancer	1.11e-05	5.39e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.11e-05	5.38e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CXCL8—urinary bladder cancer	1.11e-05	5.36e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—HRAS—urinary bladder cancer	1.1e-05	5.33e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MMP9—urinary bladder cancer	1.1e-05	5.32e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.09e-05	5.31e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—PTEN—urinary bladder cancer	1.09e-05	5.29e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MMP9—urinary bladder cancer	1.09e-05	5.28e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—CREBBP—urinary bladder cancer	1.08e-05	5.26e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CDKN1A—urinary bladder cancer	1.08e-05	5.26e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—PTEN—urinary bladder cancer	1.08e-05	5.25e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL2—urinary bladder cancer	1.07e-05	5.21e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—KRAS—urinary bladder cancer	1.07e-05	5.17e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL2—urinary bladder cancer	1.06e-05	5.13e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CCND1—urinary bladder cancer	1.05e-05	5.08e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—EP300—urinary bladder cancer	1.04e-05	5.05e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—RHOA—urinary bladder cancer	1.04e-05	5.04e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—ERBB2—urinary bladder cancer	1.04e-05	5.02e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—EP300—urinary bladder cancer	1.03e-05	5e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CCND1—urinary bladder cancer	1.03e-05	5e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MMP9—urinary bladder cancer	1.02e-05	4.93e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CDKN1A—urinary bladder cancer	1.01e-05	4.91e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—SRC—urinary bladder cancer	1.01e-05	4.91e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PTEN—urinary bladder cancer	1.01e-05	4.9e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—SRC—urinary bladder cancer	1e-05	4.86e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MMP9—urinary bladder cancer	1e-05	4.85e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CDKN1A—urinary bladder cancer	9.97e-06	4.83e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MYC—urinary bladder cancer	9.96e-06	4.83e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PTEN—urinary bladder cancer	9.95e-06	4.82e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PPARG—urinary bladder cancer	9.89e-06	4.8e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CXCL8—urinary bladder cancer	9.82e-06	4.76e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PTEN—urinary bladder cancer	9.82e-06	4.76e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—HRAS—urinary bladder cancer	9.76e-06	4.73e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—EGFR—urinary bladder cancer	9.74e-06	4.72e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—EP300—urinary bladder cancer	9.64e-06	4.67e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—ERBB2—urinary bladder cancer	9.63e-06	4.67e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CREBBP—urinary bladder cancer	9.5e-06	4.61e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—EP300—urinary bladder cancer	9.48e-06	4.6e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL2—urinary bladder cancer	9.39e-06	4.55e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—SRC—urinary bladder cancer	9.37e-06	4.54e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—EP300—urinary bladder cancer	9.36e-06	4.54e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PPARG—urinary bladder cancer	9.32e-06	4.52e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	9.26e-06	4.49e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—SRC—urinary bladder cancer	9.22e-06	4.47e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—KRAS—urinary bladder cancer	9.2e-06	4.46e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CCND1—urinary bladder cancer	9.15e-06	4.44e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CXCL8—urinary bladder cancer	9.13e-06	4.43e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MYC—urinary bladder cancer	9.07e-06	4.4e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—HRAS—urinary bladder cancer	9.07e-06	4.4e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MYC—urinary bladder cancer	8.99e-06	4.36e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	8.96e-06	4.34e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MMP9—urinary bladder cancer	8.89e-06	4.31e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PTGS2—urinary bladder cancer	8.88e-06	4.31e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—EGFR—urinary bladder cancer	8.87e-06	4.3e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CDKN1A—urinary bladder cancer	8.85e-06	4.29e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PTEN—urinary bladder cancer	8.83e-06	4.28e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—EGFR—urinary bladder cancer	8.79e-06	4.26e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL2—urinary bladder cancer	8.72e-06	4.23e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—TYMS—urinary bladder cancer	8.6e-06	4.17e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	8.51e-06	4.12e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	8.51e-06	4.12e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CCND1—urinary bladder cancer	8.5e-06	4.12e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—EP300—urinary bladder cancer	8.42e-06	4.08e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MYC—urinary bladder cancer	8.4e-06	4.07e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—KRAS—urinary bladder cancer	8.38e-06	4.06e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—KRAS—urinary bladder cancer	8.31e-06	4.03e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MYC—urinary bladder cancer	8.26e-06	4.01e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MMP9—urinary bladder cancer	8.26e-06	4e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CDKN1A—urinary bladder cancer	8.23e-06	3.99e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—EGFR—urinary bladder cancer	8.21e-06	3.98e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PTEN—urinary bladder cancer	8.21e-06	3.98e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—SRC—urinary bladder cancer	8.19e-06	3.97e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—TP53—urinary bladder cancer	8.18e-06	3.97e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GPX1—urinary bladder cancer	8.15e-06	3.95e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—EGFR—urinary bladder cancer	8.08e-06	3.92e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	8e-06	3.88e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—EP300—urinary bladder cancer	7.83e-06	3.8e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—HRAS—urinary bladder cancer	7.82e-06	3.79e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PTGS2—urinary bladder cancer	7.78e-06	3.77e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—KRAS—urinary bladder cancer	7.76e-06	3.76e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PTEN—urinary bladder cancer	7.75e-06	3.76e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—KRAS—urinary bladder cancer	7.64e-06	3.7e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—SRC—urinary bladder cancer	7.61e-06	3.69e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	7.52e-06	3.64e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—TP53—urinary bladder cancer	7.45e-06	3.61e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—EP300—urinary bladder cancer	7.39e-06	3.58e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—TP53—urinary bladder cancer	7.38e-06	3.58e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MYC—urinary bladder cancer	7.34e-06	3.56e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	7.33e-06	3.56e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—EGFR—urinary bladder cancer	7.18e-06	3.48e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—HRAS—urinary bladder cancer	7.13e-06	3.46e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—HRAS—urinary bladder cancer	7.06e-06	3.42e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TP53—urinary bladder cancer	6.9e-06	3.34e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MYC—urinary bladder cancer	6.82e-06	3.31e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PTEN—urinary bladder cancer	6.79e-06	3.29e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TP53—urinary bladder cancer	6.79e-06	3.29e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—KRAS—urinary bladder cancer	6.78e-06	3.29e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—EGFR—urinary bladder cancer	6.67e-06	3.23e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—HRAS—urinary bladder cancer	6.6e-06	3.2e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—HRAS—urinary bladder cancer	6.49e-06	3.15e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—EP300—urinary bladder cancer	6.47e-06	3.14e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PTEN—urinary bladder cancer	6.4e-06	3.1e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—KRAS—urinary bladder cancer	6.3e-06	3.06e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—EP300—urinary bladder cancer	6.1e-06	2.96e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PPARG—urinary bladder cancer	6.1e-06	2.96e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TP53—urinary bladder cancer	6.03e-06	2.92e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	5.86e-06	2.84e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—HRAS—urinary bladder cancer	5.77e-06	2.8e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TP53—urinary bladder cancer	5.6e-06	2.72e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—HRAS—urinary bladder cancer	5.36e-06	2.6e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	4.8e-06	2.33e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.18e-06	2.03e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.99e-06	1.93e-05	CbGpPWpGaD
